Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
W7XgAd7s0GPD0yMN
Listen
